Lymphoma Non-hodgkin
📧 Sign up to get email alerts when something new happens for Lymphoma Non-hodgkin.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation [NA]
A completed clinical trial evaluating an electronic mindfulness-based music therapy intervention for patients undergoing allogeneic stem cel…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy [Phase 2]
Phase 2 trial evaluating siltuximab for treating cytokine release syndrome and ICANS associated with CAR-T cell therapy; study completed wit…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies [Phase 1, Phase 2]
A safety and efficacy trial update for JCAR017 combinations in relapsed/refractory B-cell malignancies across Phase 1 and Phase 2, completed…
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for ASN002 in relapsed/refractory lymphoma and advanced solid tumors; the study status is TERMINATED with re…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for non-myeloablative allogeneic transplantation using TLI and ATG in patients with cutaneous T-cell lymphoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL [Phase 1, Phase 2]
Dose-escalation early-stage trial assessing safety of PBCAR20A in relapsed/refractory Non-Hodgkin's Lymphoma and relapsed/refractory Chronic…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant [Phase 1, Phase 2]
A phase 1/2 safety study evaluating gene-modified donor T-cells after TCRαβ+ depleted stem cell transplant was terminated; results were post…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant [Phase 1, Phase 2]
Clinical trial update for a phase 1/2 study evaluating gene-modified donor T-cells after TCR alpha beta–negative depleted stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT [Phase 2]
Phase 2 trial evaluating sirolimus and mycophenolate mofetil for GVHD prophylaxis in myeloablative matched related donor hematopoietic cell …
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies [Phase 1]
Phase 1 trial evaluating a fully-human anti-CD19 CAR-T cell therapy for treating B-cell malignancies, with completed status and posted resul…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial investigating mitoguazone dihydrochloride in AIDS-related non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Preventing Stem Cell Transplant Complications With a Blood Separator Machine [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating a blood separator machine to prevent complications after stem cell transplant.
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Randomized Double Cord Blood Transplant Study [Phase 2]
Phase 2 randomized double cord blood transplant study for acute leukemias and related disorders has completed enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Phase 2]
Phase 2 trial update on re-induction therapy for relapsed pediatric T-cell acute lymphoblastic leukemia or lymphoma; study terminated with p…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant [Phase 2]
Phase II multicenter trial evaluating CD26 inhibition with sitagliptin for engraftment after umbilical cord blood transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) [Phase 3]
Phase 3 trial comparing Rituxan/BEAM versus Bexxar/BEAM in autologous stem cell transplantation for non-Hodgkin lymphoma has completed with …
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies [Phase 2]
Phase 2 clinical trial update on mismatched family member donor stem cell transplantation in children and young adults with high-risk hemato…